Healthcare Sector

Members of Parliament invested in the Healthcare Sector

156 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£127.78	195.51%	£206,859.38
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£127.78	177.00%	£193,899.84
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£14,364.00	19.46%	£83,622.75
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£14,364.00	248.98%	£244,285.71
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£14,364.00	270.54%	£259,378.31
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£14,364.00	93.53%	£135,472.92
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£14,364.00	22.00%	£85,398.34
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£14,364.00	438.68%	£377,078.57
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£14,364.00	18.16%	£82,714.71
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£14,364.00	165.17%	£185,615.65
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£14,364.00	20.46%	£84,324.05
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£14,364.00	40.41%	£98,287.39
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£14,364.00	79.44%	£125,606.50
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£14,364.00	388.90%	£342,232.81
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£0.36	-89.12%	£7,613.29
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£54.28	45.17%	£101,620.75
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£54.28	1.59%	£71,113.60
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£54.28	26.88%	£88,817.20
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£54.28	37.84%	£96,485.52
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£54.28	28.29%	£89,803.82
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£54.28	37.45%	£96,216.76
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£54.28	21.30%	£84,907.26
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£54.28	23.31%	£86,315.31
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£54.28	45.25%	£101,675.14
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£242.04	46.66%	£102,664.97
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£242.04	97.36%	£138,150.68
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£242.04	232.98%	£233,082.94
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£242.04	297.24%	£278,069.91
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£242.04	49.67%	£104,766.26
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£223.01	145.23%	£171,659.87**
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£186.26	158.14%	£180,698.96
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£186.26	-25.16%	£52,386.87
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£316.70	151.15%	£175,804.93**
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£277.05	9.41%	£76,587.55
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£277.05	-43.47%	£39,573.72
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£277.05	-48.49%	£36,058.79
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£277.05	-46.54%	£37,424.74
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£277.05	-53.39%	£32,627.02
Oct '25	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£361.15	£356.26	-1.35%	£69,052.20**
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,168.00	73.68%	£121,578.02
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£475.89	13.81%	£79,667.81
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£475.89	3.63%	£72,537.89
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£475.89	-18.46%	£57,076.79
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£475.89	2.78%	£71,942.60
Aug '25	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£477.41	£475.89	-0.32%	£69,777.13
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£118.20	-80.71%	£13,506.37
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£118.20	-63.06%	£25,856.25
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£38.02	4.59%	£73,215.96
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£38.02	-62.61%	£26,171.70
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£38.02	-69.03%	£21,681.47
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£38.02	-71.77%	£19,763.85
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£115.46	-31.31%	£48,079.71
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£115.46	-29.09%	£49,638.86
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£154.25	74.53%	£122,171.31
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£154.25	133.54%	£163,478.64
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£154.25	185.43%	£199,801.20
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£186.20	-18.15%	£57,292.31
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£318.20	26.35%	£88,441.53
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£318.20	2.76%	£71,932.83
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£318.20	24.39%	£87,075.84
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£318.20	5.02%	£73,511.55
Nov '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£309.00	£318.20	2.98%	£72,084.15
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£108.14	328.00%	£299,601.03
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£108.14	-0.62%	£69,562.58
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£108.14	228.69%	£230,085.09
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£15.07	-85.11%	£10,423.91
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£26.86	37.43%	£96,200.53
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£26.86	-7.45%	£64,783.62
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£33.04	46.16%	£102,313.46
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£33.04	57.48%	£110,236.27
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£283.32	225.32%	£227,723.06
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£337.21	385.75%	£340,027.37
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£337.21	22.62%	£85,835.27
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£45.10	-5.65%	£66,046.02
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£45.10	-17.93%	£57,452.23
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£19.15	49.49%	£104,644.81
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Dec '25	Lord Sassoon	Medtronic / NYQ:MDT	£100.77	£87.38	-13.29%	£60,698.62
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£76.07	-4.24%	£67,030.46
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£77.90	47.93%	£103,551.08**
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£39.13	-58.92%	£28,753.94
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£166.92	-39.02%	£42,682.74
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£225.37	40.15%	£98,102.73
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£479.27	72.49%	£120,744.64
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£479.27	36.63%	£95,638.13
Oct '25	Lord Carter of Coles	Intuitive Surgical / NMS:ISRG	£551.30	£479.27	-13.07%	£60,854.16
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£3.87	11.21%	£77,844.83**
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.18	-99.14%	£599.29
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£532.58	1,616.89%	£1,201,824.67
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£25.95	3.76%	£72,630.37
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£2,695.00	0.63%	£70,444.36
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£571.21	1,806.58%	£1,334,602.90
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£977.25	33.63%	£93,538.48
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,209.00	-40.33%	£41,771.96
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£1.13	-97.39%	£1,827.21
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£848.20	52.28%	£106,596.05
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£4.98	255.71%	£249,000.00
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.25	93.85%	£135,695.19**
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.41	-52.17%	£33,478.26**
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£3.28	70.83%	£119,583.33
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£0.94	-9.13%	£63,605.77
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£26.94	79.00%	£125,302.33
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.03	-98.28%	£1,207.14
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.23	-98.08%	£1,341.67
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£10.55	-0.66%	£69,538.61
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£8.25	-26.67%	£51,333.33
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£45.87	52.49%	£106,745.34
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£53.39	-52.32%	£33,374.71
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.98	-72.68%	£19,124.29
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£373.00	10.98%	£77,685.21
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£6.64	-47.51%	£36,743.08
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£210.80	1.59%	£71,113.25
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£210.80	-22.84%	£54,011.71
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.57	-97.79%	£1,548.08
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£72.00	-35.71%	£45,000.00
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£72.00	39.81%	£97,864.08
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£114.29	554.21%	£457,945.08
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£4.35	-85.50%	£10,150.00
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£4.59	16.20%	£81,341.77

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.